
Hodgkin lymphoma Program in Pharmaceutical Benefits Scheme (PBS) 012-18042700

-   Background
-   Process
-   Resources

[Expand/Collapse all sections]Expand all

On this Page:

Hodgkin lymphoma restriction and item codes

These attachments may not be printed, broadcast or released externally.
For contact details and more information, see Information Publication
Scheme.

[\\INTERNAL.DEPT.LOCAL\Shared\NAT\SERDELEXCEL\WORKPRODIMP\Operation
Blueprint Migration\RDT Release
Icons\32w\icon-hidden-attachment.png]Hodgkin lymphoma – brentuximab and
pembrolizumab restriction and item codes

Contact details

Complex Drugs Programs team

Forms

Relapsed or refractory Hodgkin lymphoma – brentuximab (failed ASCT or is
ASCT naïve) initial PBS authority form (PB205)

Pembrolizumab - Relapsed or refractory Hodgkin lymphoma - pembrolizumab
initial PBS authority application (PB232)

Services Australia website

Hodgkin lymphoma

External websites

PBS schedule for Hodgkin lymphoma

                                   

-   Services Australia ABN 90 794 605 008 
